| 000 | 02766 a2200781 4500 | ||
|---|---|---|---|
| 005 | 20250515040732.0 | ||
| 264 | 0 | _c20070109 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 024 | 7 |
_a10.1124/jpet.106.109058 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBraselmann, Sylvia | |
| 245 | 0 | 0 |
_aR406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 2006 |
||
| 300 |
_a998-1008 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen-Antibody Complex _xphysiology |
| 650 | 0 | 4 |
_aArthritis, Experimental _xpathology |
| 650 | 0 | 4 |
_aArthus Reaction _xphysiopathology |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aBasophils _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCrystallography |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aFluorescence Polarization Immunoassay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xbiosynthesis |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aOxazines _xpharmacokinetics |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyridines _xpharmacokinetics |
| 650 | 0 | 4 |
_aReceptors, Fc _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSpleen _xenzymology |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 700 | 1 | _aTaylor, Vanessa | |
| 700 | 1 | _aZhao, Haoran | |
| 700 | 1 | _aWang, Su | |
| 700 | 1 | _aSylvain, Catherine | |
| 700 | 1 | _aBaluom, Muhammad | |
| 700 | 1 | _aQu, Kunbin | |
| 700 | 1 | _aHerlaar, Ellen | |
| 700 | 1 | _aLau, Angela | |
| 700 | 1 | _aYoung, Chi | |
| 700 | 1 | _aWong, Brian R | |
| 700 | 1 | _aLovell, Scott | |
| 700 | 1 | _aSun, Thomas | |
| 700 | 1 | _aPark, Gary | |
| 700 | 1 | _aArgade, Ankush | |
| 700 | 1 | _aJurcevic, Stipo | |
| 700 | 1 | _aPine, Polly | |
| 700 | 1 | _aSingh, Rajinder | |
| 700 | 1 | _aGrossbard, Elliott B | |
| 700 | 1 | _aPayan, Donald G | |
| 700 | 1 | _aMasuda, Esteban S | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 319 _gno. 3 _gp. 998-1008 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.106.109058 _zAvailable from publisher's website |
| 999 |
_c16531195 _d16531195 |
||